Renovaro Biosciences IncEigentümerstruktur
| Preis (2024-05-01) | 52W Hoch | 52W Tief |
| 1.47 USD | 5,25 USD | 0,393 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| - USD | - | - | - | - | - |
| #Shares | Short [%] | Short Ratio |
| 143.668.000 | 2,31 | 6,5 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Renovaro Biosciences Inc
Mitarbeiter 12
Handelsplatz NASDAQ
Ticker Symbol RENB
IPO Datum 2015-02-02
Adresse 2080 Century Park East, Los Angeles, CA, United States, 90067
Webseite https://renovarobio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Hon. Mark R. Dybul M.D. | CEO, Director & Member of HBV Scientific Advisory Board |
| 2 | Dr. Francois Binette M.Sc., Ph.D. | COO and Executive VP for Research & Development |
| 3 | Dr. Serhat Gümrükcü | Co-Founder & Inventor |
| 4 | Mr. Simon Tarsh | Interim Chief Financial Officer |
| 5 | Mr. Greg Duczynski Ph.D. | Senior Vice President for Clinical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 2 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 3 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 5 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 6 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corporation | 0,00% | 0,00 Mio. USD |
| 8 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 9 | 683 Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 10 | Qube Research & Technologies | 0,00% | 0,00 Mio. USD |
| 11 | JANE STREET GROUP, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Citigroup Inc | 0,00% | 0,00 Mio. USD |
| 13 | Bank of America Corp | 0,00% | 0,00 Mio. USD |
| 14 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 15 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 16 | Balyasny Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 17 | Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 18 | MSA Advisors LLC | 0,00% | 0,00 Mio. USD |
| 19 | ExodusPoint Capital Management, LP | 0,00% | 0,00 Mio. USD |
| 20 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |